ID

16055

Descrizione

Documentation part: Pregnancy Information A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Keywords

versioni (1)

1. 27/06/16 27/06/16 -

Caricato su

27 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza